Hepatitis B functional cure shows promise in late-stage clinical trial

Vidcast:  https://www.instagram.com/p/DbOljwysK0r/For decades, people living with chronic hepatitis B have faced the reality of lifelong medication to keep the virus under control. But this week brought encouraging news from researchers across the globe working collaboratively.In a late-stage clinical trial, an experimental medication called bepirovirsen enabled about one in five patients to stop treatment while maintaining long-term suppression of the virus. Researchers describe this as a functional cure—meaning the virus remains under control without the need for continuous medication. While it isn't a cure for everyone, it's one of the most promising advances against hepatitis B in years.If future studies confirm these results and regulators approve the treatment, millions of people worldwide could eventually have an alternative to lifelong therapy.References for this report are available on my website.#HepatitisB #MedicalResearch #ClinicalTrials #LiverHealth #HealthcareInnovation